Search

everythinglearnresearchcommunity

for

Search:↓

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

People with hair loss feel distressed and need better, trustworthy information sources.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Women with pattern hair loss often have higher blood sugar, cholesterol, blood pressure, and waist size, suggesting a link between hair loss and metabolic syndrome.

Female Pattern Hair Loss is linked to genetics, diet, stress, and certain health conditions.

Minoxidil 2% is more effective for female hair loss, but botanicals have fewer side effects.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.